Posted in | News | Gold | Mining Business

Inca One Reports Consistent Tonnage Throughput and Gold Production at Chala One

INCA ONE GOLD CORP. is pleased to announce that since its press release of February 24, 2015, its wholly owned subsidiary Chala One SAC has recovered an additional total of 1,665 ounces (51,828 grams) of gold and 1,119 ounces (34,789 grams) of silver from 2,303 tonnes of material in connection with operations undertaken from February 25, 2015, through April 8, 2015.

Including the results announced today, the Company has processed a total of 4,196 tonnes of material and recovered a total of 3,375 ounces of gold and 2,619 ounces of silver since December 3, 2014. This amounts to 0.80 ounces of gold recovered per tonne of material processed.

Average production throughput at the plant since February 1, 2015 has been approximately 50 tonnes per day ("TPD"). The Company, in its March 25, 2015 press release announced that as of February 1, it has reached commercial production at the Chala One plant. Overall production is now ramping up to the full 100 TPD capacity.

"Now that we have reached commercial production at Chala One, we are pleased to see consistent tonnage throughput and gold production," said Edward Kelly, Inca One's President and CEO. "We expect to maintain this operational consistency paying attention to all parameters that relate to maintaining good levels of recovery and low unit costs as we proceed to ramp to full capacity and thereby meet or exceed our performance objectives and forecasts for 2015."

Van Phu Bui, B.Sc, PGeo, a director of the Company and a qualified person under the terms of National Instrument 43-101, standards of disclosure for mineral projects, has approved the technical information in this news release.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.